CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Jonge, E.
Right arrow Articles by van der Poll, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Jonge, E.
Right arrow Articles by van der Poll, T.

 Previous Article

Clinical and Diagnostic Laboratory Immunology, May 2003, p. 495-497, Vol. 10, No. 3
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.3.495-497.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Activation of Coagulation by Administration of Recombinant Factor VIIa Elicits Interleukin 6 (IL-6) and IL-8 Release in Healthy Human Subjects

Evert de Jonge,1* Philip W. Friederich,2 George P. Vlasuk,3 William E. Rote,3 Margaretha B. Vroom,1 Marcel Levi,2 and Tom van der Poll2,4

Departments of Intensive Care,1 Internal Medicine,2 Laboratory of Experimental Internal Medicine, Academic Medical Center, University of Amsterdam, The Netherlands,4 Corvas International, San Diego, California3

Received 18 July 2002/ Returned for modification 16 December 2002/ Accepted 21 January 2003

The activation of coagulation has been shown to contribute to proinflammatory responses in animal and in vitro experiments. Here we report that the activation of coagulation in healthy human subjects by the administration of recombinant factor VIIa also elicits a small but significant increase in the concentrations of interleukin 6 (IL-6) and IL-8 in plasma. This increase was absent when the subjects were pretreated with recombinant nematode anticoagulant protein c2, the inhibitor of tissue factor-factor VIIa.

* Corresponding author. Mailing address: Department of Intensive Care, Academic Medical Center, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands. Phone: 31 20 5662509. Fax: 31 20 6972988. E-mail: e.dejonge{at}amc.uva.nl.

Clinical and Diagnostic Laboratory Immunology, May 2003, p. 495-497, Vol. 10, No. 3
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.3.495-497.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.